EDP1503 reduces the activation of immunosuppressive cells such as myeloid-derived suppressor cells (MDSCs) and regulatory T cells (Tregs), while increasing the number of activated, immune-stimulating DCs, IFN-γ-producing tumor-infiltrating lymphocytes, and cytotoxic CD8+ T cells. Here, CD8A is linked to neoplasm.